Skip to main content Skip to main navigation menu Skip to site footer

Hypercoagulation state in infant with COVID-19: a case report


Background: COVID-19 pandemic is not over yet, and the clinical manifestations of this newly emerged disease vary due to the rapid mutation of SARS-CoV-2 as its causative agent. The SARS-CoV-2 infection will stimulate the release of proinflammatory cytokines in large amounts, which further leads to hypercoagulation. The aim of this study is to describe a case of COVID-19 with hypercoagulation and what can be done to prevent serious complications.

Case: 1.5-month-old baby boy presented with a complaint of coughing for 10 days. It was accompanied by persistent fever, diarrhea, and vomiting, but no shortness of breath or rhinorrhea was reported. It was known that his parents, whom he was living with, were self–isolating due to COVID – 19. On physical examinations, his vital signs were within normal limits except for axillary temperature, which was tested at 38.3°C. Laboratory results showed a prolongation of coagulation time (PT: 8,3 seconds, APTT: 23,2 seconds), elevated D-Dimer (>10.000 ng/mL), and a positive COVID-19 PCR test. He was diagnosed with a hypercoagulation state in severe COVID-19 and received both supportive and anticoagulant therapy. His condition improved, and he was discharged in good condition after 12 days of hospitalization.

Conclusion: In order to get good outcomes, thorough examinations and comprehensive management have to be ensured in patients with a hypercoagulation state due to severe COVID-19.



  1. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.
  2. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782–793.
  3. American Academy of Pediatrics. Children and COVID-19: State-Level Data Report [Internet]. AAP. 2021. Available from:
  4. Satgas COVID 19. Situasi Virus Corona [Internet]. Satgas COVID 19.2021. Available from:
  5. PDPI, PERKI, PAPDI, PERDATIN, IDAI. Pedoman Tatalaksana COVID-19 3th edition. 2020. Jakarta;Satgas COVID-19. p1 - 149.
  6. Henry BM, Benoit SW, de Oliveira MHS, et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review. Clin Biochem. 2020;81:1-8.
  7. Kosmeri C, Koumpis E, Tsabouri S, Siomou E, Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020;67(12):e28745.
  8. Guo CX, He L, Yin JY, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med. 2020;18(1):250. Published 2020 Aug 6.
  9. Foust AM, McAdam AJ, Chu WC, et al. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020;55(9):2213-2224.
  10. Sun D, Zhu F, Wang C, et al. Children Infected With SARS-CoV-2 From Family Clusters. Front Pediatr. 2020;8:386. Published 2020 Jun 23.
  11. Ji LN, Chao S, Wang YJ, et al. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World J Pediatr. 2020;16(3):267-270.
  12. Mayor S. Covid-19: UK studies find gastrointestinal symptoms are common in children. BMJ. 2020;370:m3484. Published 2020 Sep 7.
  13. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107(36):15880-15885. doi:10.1073/pnas.1005743107.
  14. Becker RC. COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54-67.
  15. Di Nardo M, van Leeuwen G, Loreti A, et al. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children. Pediatr Res. 2021;89(5):1101-1108.
  16. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
  17. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. Published 2020 Mar 13.
  18. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020;14(2):126-135.
  19. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116-1120. doi:10.1515/cclm-2020-0188.
  20. Kwaan HC, Lindholm PF. The Central Role of Fibrinolytic Response in COVID-19—A Hematologist's Perspective. International Journal of Molecular Sciences. 2021; 22(3):1283.
  21. Hoffbrand AV, Moss PAH. Kapita Selekta Hematologi. Jakarta EGC. 2013. p293-350.
  22. Outzoukas AE, Benjamin DK, Zimmerman KO. Remdesivir: Preliminary Data and Clinical Use Versus Recommended Use. Pediatrics. 2021;147(5). p1-2.
  23. Carneiro JDA, Ramos GF, de Carvalho WB, Johnston C, Delgado AF. Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2. Clinics (Sao Paulo). 2020;75:e2252. Published 2020 Dec 9.

How to Cite

Wijaya, T., Hsieh, P. P., Melinda, F., & Suarca, I. K. (2022). Hypercoagulation state in infant with COVID-19: a case report. Indonesia Journal of Biomedical Science, 16(1), 66–69.




Search Panel